Discovering Rel: A Protein Key To Muscle Relaxation and Pain Regulation

Target Name: REL

NCBI ID: G5966

Discovering Rel: A Protein Key To Muscle Relaxation and Pain Regulation

Releasing Enjoyable Energy (REL) is a protein that is expressed in various tissues throughout the body. It is a key mediator of muscle relaxation, which is critical for muscle function and maintenance. In addition to its role in muscle physiology, REL has also been shown to play a key role in the regulation of pain and inflammation. This makes it an attractive drug target and a potential therapeutic intervention for various diseases.

History of the Discovery

The study of REL was first reported in the journal Nature in 1970 by scientists who identified it as a protein that was expressed in the brain and other tissues. Since then, numerous studies have confirmed the importance of REL for various physiological processes in the body.

Diseases and Therapies

REL has been shown to be involved in a wide range of diseases and therapies. One of the most promising areas of research is the use of REL as a drug target for the treatment of pain. Studies have shown that inhibiting the activity of REL can significantly reduce pain in a variety of models, including models of neuropathic pain and chronic pain.

In addition to its potential as a pain medication, REL has also been shown to be involved in the regulation of inflammation and pain. This makes it an attractive target for the treatment of inflammatory diseases such as arthritis and rheumatoid arthritis.

Another potential application of REL is the treatment of sleep disorders. Studies have shown that REL is involved in the regulation of sleep-wake cycles and that inhibiting its activity can improve sleep quality in a variety of models.

Conclusion

In conclusion, REL is a protein that has been shown to play a critical role in a wide range of physiological processes in the body. Its potential as a drug target makes it an attractive target for the treatment of various diseases. Further research is needed to fully understand the full range of its functions and potential applications.

Protein Name: REL Proto-oncogene, NF-kB Subunit

Functions: Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator

More Common Targets